Utilization of Rh prophylaxis.
D001787:Blood Group Incompatibility / Q000188:drug therapy / Q000517:prevention & control*; D003237:Connecticut; D004899:Erythroblastosis, Fetal / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007087:Illinois; D007165:Immunosuppression Therapy / Q000706:statistics & numerical data*; D008404:Massachusetts; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000276:immunology* / Q000627:therapeutic use*; D018029:Rho(D) Immune Globulin; D065227:Transfusion Reaction; D005719:gamma-Globulins / Q000627:therapeutic use*
D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin; D005719:gamma-Globulins